10-K · August 27, 2026
LifeVantage's fiscal 2026 results show a material deterioration in demand: revenue declined 20.1% to $182.586 million, operating margin fell to 3.4% from 5.4%, and active accounts declined 21.2% to 104,000. The…
LFVN earnings analysis
10-Q · Filed November 9, 2026 · Our reading of the company's report
The latest report
The quarter showed sequential improvement in revenue, gross margin, operating margin, and EPS, with revenue of $48 million, gross margin of 79.5%, operating margin of 4.8%, and diluted EPS of $0.17. However, free cash…
Read full summary
The quarter showed sequential improvement in revenue, gross margin, operating margin, and EPS, with revenue of $48 million, gross margin of 79.5%, operating margin of 4.8%, and diluted EPS of $0.17. However, free cash flow was negative $3 million versus positive $4 million in the prior quarter. The provided filing text contains no quantitative guidance, no segment disclosure, and states that there were no material changes to previously disclosed risk factors.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
From revenue to operating profit
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $0.17
What stood out
-
Sequential margin recovery
Revenue was $48 million, up from $42 million in the immediately prior quarter, while gross margin improved to 79.5% from 78.0% and operating margin improved to 4.8% from 3.9%.
-
EPS improved sequentially
Diluted EPS increased to $0.17 from $0.10 in the prior quarter, although the filing text provided does not include the prior-year comparative EPS.
-
Cash conversion weakened
The company reported free cash flow of negative $3 million for the period, compared with positive $4 million in the prior quarter.
-
Controls assessed effective
Management concluded that disclosure controls were designed and operating effectively as of September 30, 2026.
-
Repurchase capacity remains
The company had $58,534,993 remaining under its stock-repurchase authorization at September 30, 2026, out of the $60.0 million program approved in January 2026.
What to watch
-
No new risk-factor disclosure
The filing states that no material changes occurred to previously disclosed risk factors, but the company continues to identify risks that could materially affect results, cash flows, and future prospects.
-
Negative free cash flow
Free cash flow was negative $3 million versus positive $4 million in the prior quarter, indicating weaker quarterly cash generation despite the sequential improvement in operating margin.
-
Repurchase execution uncertain
The company reported no share repurchases during the three months ended September 30, 2026, while retaining authorization for up to $60.0 million of purchases through December 31, 2027.
Management's outlook
No quantitative revenue or EPS outlook was disclosed in the provided 10-Q text.
Earlier filings 4
10-Q · May 6, 2026
LifeVantage Corporation's Q3 2026 results reflect a significant decline in revenue and earnings, continuing from prior quarters. Revenue decreased to $43.7 million, down from $58.4 million in Q3 2025, resulting in an…
10-K · September 4, 2025
LifeVantage frames its strategy around nutrigenomics and a direct‑selling model, emphasizing product innovation (notably the patent‑pending MindBody GLP‑1 System™ launched in fiscal 2025), technology‑enabled consultant…
10-K · August 28, 2024
LifeVantage positions itself as a nutrigenomics-focused direct‑selling company emphasizing product ‘activation’ (Protandim®, TrueScience®, AXIO®, etc.), technology-enabled consultant tools, and expanded compensation and…
Smart money in LFVN
Totals from the last full session. Insider and politician figures cover 90 days.
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.
See every LFVN trade live.
The free pages stop at the last full session. Trader shows every trade as it prints.
Start tracking No card needed.